Cite this article: Patakfalvi L, Brazeau A-S, Dasgupta K. (2018) Physician experiences with sodium-glucose cotransporter (SGLT2) inhibitors, a new class of medications in type 2 diabetes, and adverse effects. The gene discussed is SLC5A2; the disease is type 2 diabetes mellitus.